Literature DB >> 20112380

Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice.

Firas M Kara1, Stephen B Doty, Adele Boskey, Steven Goldring, Mone Zaidi, Bertil B Fredholm, Bruce N Cronstein.   

Abstract

OBJECTIVE: Accelerated osteoclastic bone resorption plays a central role in the pathogenesis of osteoporosis and other bone diseases. Because identifying the molecular pathways that regulate osteoclast activity provides a key to understanding the causes of these diseases and developing new treatments, we studied the effect of adenosine A(1) receptor blockade or deletion on bone density.
METHODS: The bone mineral density (BMD) in adenosine A(1) receptor-knockout (A(1)R-knockout) mice was analyzed by dual x-ray absorptiometry (DXA) scanning, and the trabecular and cortical bone volume was determined by microfocal computed tomography (micro-CT). The mice were ovariectomized or sham-operated, and 5 weeks after surgery, when osteopenia had developed, several parameters were analyzed by DXA scanning and micro-CT. A histologic examination of bones obtained from A(1)R-knockout and wild-type mice was carried out. Visualization of osteoblast function (bone formation) after tetracycline double-labeling was performed by fluorescence microscopy.
RESULTS: Micro-CT analysis of bones from A(1)R-knockout mice showed significantly increased bone volume. Electron microscopy of bones from A(1)R-knockout mice showed the absence of ruffled borders of osteoclasts and osteoclast bone resorption. Immunohistologic analysis demonstrated that although osteoclasts were present in the A(1)R-knockout mice, they were smaller and often not associated with bone. No morphologic changes in osteoblasts were observed, and bone-labeling studies revealed no change in the bone formation rates in A(1)R-knockout mice.
CONCLUSION: These results suggest that the adenosine A(1) receptor may be a useful target in treating diseases characterized by excessive bone turnover, such as osteoporosis and prosthetic joint loosening.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20112380      PMCID: PMC2853194          DOI: 10.1002/art.27219

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Coffee, tea and caffeine consumption in relation to osteoporotic fracture risk in a cohort of Swedish women.

Authors:  H Hallström; A Wolk; A Glynn; K Michaëlsson
Journal:  Osteoporos Int       Date:  2006-05-04       Impact factor: 4.507

2.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

3.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor.

Authors:  B Johansson; L Halldner; T V Dunwiddie; S A Masino; W Poelchen; L Giménez-Llort; R M Escorihuela; A Fernández-Teruel; Z Wiesenfeld-Hallin; X J Xu; A Hårdemark; C Betsholtz; E Herlenius; B B Fredholm
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

4.  Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

Authors:  A M Parfitt; M K Drezner; F H Glorieux; J A Kanis; H Malluche; P J Meunier; S M Ott; R R Recker
Journal:  J Bone Miner Res       Date:  1987-12       Impact factor: 6.741

Review 5.  Epidemiology of osteoporosis and osteoporotic fractures.

Authors:  S R Cummings; J L Kelsey; M C Nevitt; K J O'Dowd
Journal:  Epidemiol Rev       Date:  1985       Impact factor: 6.222

6.  Adenosine A(2A) receptors play a role in the pathogenesis of hepatic cirrhosis.

Authors:  Edwin S L Chan; Maria Carmen Montesinos; Patricia Fernandez; Avani Desai; David L Delano; Herman Yee; Allison B Reiss; Michael H Pillinger; Jiang-Fan Chen; Michael A Schwarzschild; Scott L Friedman; Bruce N Cronstein
Journal:  Br J Pharmacol       Date:  2006-06-19       Impact factor: 8.739

7.  Bifurcation of osteoclasts and dendritic cells from common progenitors.

Authors:  T Miyamoto; O Ohneda; F Arai; K Iwamoto; S Okada; K Takagi; D M Anderson; T Suda
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexate.

Authors:  S L Morgan; J E Baggott; H Refsum; P M Ueland
Journal:  Clin Pharmacol Ther       Date:  1991-11       Impact factor: 6.875

9.  Pathological role of osteoclast costimulation in arthritis-induced bone loss.

Authors:  Sae Ochi; Masahiro Shinohara; Kojiro Sato; Hans-Jürgen Gober; Takako Koga; Tatsuhiko Kodama; Toshiyuki Takai; Nobuyuki Miyasaka; Hiroshi Takayanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-25       Impact factor: 11.205

Review 10.  Cells of the synovium in rheumatoid arthritis. Osteoclasts.

Authors:  Georg Schett
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  49 in total

1.  Adenosine A2A receptor activation prevents wear particle-induced osteolysis.

Authors:  Aránzazu Mediero; Sally R Frenkel; Tuere Wilder; Wenjie He; Amitabha Mazumder; Bruce N Cronstein
Journal:  Sci Transl Med       Date:  2012-05-23       Impact factor: 17.956

2.  Adenosine A1 receptor regulates osteoclast formation by altering TRAF6/TAK1 signaling.

Authors:  W He; B N Cronstein
Journal:  Purinergic Signal       Date:  2012-02-05       Impact factor: 3.765

3.  Does adenosine play a role in bone formation, resorption and repair?

Authors:  Bronwen A J Evans
Journal:  Purinergic Signal       Date:  2012-06       Impact factor: 3.765

Review 4.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 5.  International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.

Authors:  Bertil B Fredholm; Adriaan P IJzerman; Kenneth A Jacobson; Joel Linden; Christa E Müller
Journal:  Pharmacol Rev       Date:  2011-02-08       Impact factor: 25.468

6.  CD73-generated adenosine promotes osteoblast differentiation.

Authors:  Masahide Takedachi; Hiroyuki Oohara; Brenda J Smith; Mitsuyoshi Iyama; Mariko Kobashi; Kenichiro Maeda; Courtney L Long; Mary B Humphrey; Barbara J Stoecker; Satoru Toyosawa; Linda F Thompson; Shinya Murakami
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

7.  Regeneration of a Pediatric Alveolar Cleft Model Using Three-Dimensionally Printed Bioceramic Scaffolds and Osteogenic Agents: Comparison of Dipyridamole and rhBMP-2.

Authors:  Christopher D Lopez; Paulo G Coelho; Lukasz Witek; Andrea Torroni; Michael I Greenberg; Dean L Cuadrado; Audrey M Guarino; Jonathan M Bekisz; Bruce N Cronstein; Roberto L Flores
Journal:  Plast Reconstr Surg       Date:  2019-08       Impact factor: 4.730

8.  Age-dependent variations of cancellous bone in response to ovariectomy in C57BL/6J mice.

Authors:  Sheng Zhou; Guanghu Wang; Liang Qiao; Qiting Ge; Dongyang Chen; Zhihong Xu; Dongquan Shi; Jin Dai; Jinzhong Qin; Huajian Teng; Qing Jiang
Journal:  Exp Ther Med       Date:  2018-02-06       Impact factor: 2.447

Review 9.  Adenosine and bone metabolism.

Authors:  Aránzazu Mediero; Bruce N Cronstein
Journal:  Trends Endocrinol Metab       Date:  2013-03-14       Impact factor: 12.015

Review 10.  Adenosine receptors as drug targets--what are the challenges?

Authors:  Jiang-Fan Chen; Holger K Eltzschig; Bertil B Fredholm
Journal:  Nat Rev Drug Discov       Date:  2013-04       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.